It’s a very rewarding trading day for investors in Spark Therapeutics (ONCE) with shares skyrocketing 120%, making the stock Wall Street’s bull of …
Spark Therapeutics (NASDAQ:ONCE) saw its shares crater by as much as 30% this morning on exceptionally high volume. The drop was triggered by …
J.P.
Spark Therapeutics Inc (NASDAQ:ONCE) tanked over 35% today after data from a Phase 1/2 study showed that patients suffering from hemophilia A may not …
Spark Therapeutics Has a Viable Hep A Program on Its Hands Spark Therapeutics Inc (NASDAQ:ONCE) shares are jumping almost 20% after the biotech …
Celator Pharmaceuticals Inc Roth Capital analyst Joseph Pantginis weighs in today on Celator Pharmaceuticals Inc (NASDAQ:CPXX), after the biotech company announced that the FDA granted Breakthrough Therapy …
The latest in the onslaught of biotech initial public offerings, Spark Therapeutics (ONCE) priced at $23 on Thursday evening. Twelve hours later, the stock opened at …
Another rough and tumble week ending with the SP 500 down sharply 3 straight days ending the week around 1994, just 4 points …
